TA-1801 is primarily utilized in the field of medical research, particularly in the development of therapeutic agents. It has shown potential in targeting specific cellular pathways, making it a candidate for the treatment of various diseases, including cancer and autoimmune disorders. Researchers are exploring its efficacy in inhibiting abnormal cell growth and modulating immune responses. Additionally, TA-1801 is being studied for its role in enhancing the effectiveness of existing treatments when used in combination therapies. Its application extends to preclinical studies, where it aids in understanding disease mechanisms and evaluating new drug candidates.